Literature DB >> 12763413

Surgical management of pancreaticocutaneous fistula.

Miranda Voss1, Amjad Ali1, W Steve Eubanks1, Theodore N Pappas1.   

Abstract

Although enteric drainage of the fistula tract is a widely accepted treatment for pancreaticocutaneous fistula, few data have been published on the outcome of this procedure. We conducted a retrospective chart review of 30 patients with pancreaticocutaneous fistula who underwent surgical management at a single institution over a 13-year period. The operative morbidity rate was 30%. Overall the incidence of recurrent ductal leaks requiring further intervention was 23%. Six of seven patients who had a recurrence had an ongoing inflammatory pathology, and three of seven had pancreas divisum. Recurrence was most likely when cystenterostomy was used. Enteric drainage of pancreaticocutaneous fistulas is not always curative. Fistulojejunostomy gives a better outcome than cystenterostomy. Recurrence may be expected in patients with continuing inflammatory ductal pathology.

Entities:  

Mesh:

Year:  2003        PMID: 12763413     DOI: 10.1016/S1091-255X(02)00185-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

Review 1.  Surgery and pancreas divisum: a dwindling role?

Authors:  R Pathak; A M Cooperman
Journal:  Surg Clin North Am       Date:  2001-04       Impact factor: 2.741

2.  A single-institution experience with fistulojejunostomy for external pancreatic fistulas.

Authors:  C Bassi; G Butturini; R Salvia; C Contro; A Valerio; M Falconi; P Pederzoli
Journal:  Am J Surg       Date:  2000-03       Impact factor: 2.565

3.  Pancreatic cutaneous fistulas.

Authors:  M J Zinner; R R Baker; J L Cameron
Journal:  Surg Gynecol Obstet       Date:  1974-05

4.  Are cystgastrostomy and cystjejunostomy equivalent operations for pancreatic pseudocysts?

Authors:  K A Newell; T Liu; G V Aranha; R A Prinz
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

5.  Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; P K Sauter; J Coleman; T A Sohn; K A Campbell; M A Choti
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Surgical treatment of pancreatic pseudocysts.

Authors:  H Köhler; A Schafmayer; F E Lüdtke; G Lepsien; H J Peiper
Journal:  Br J Surg       Date:  1987-09       Impact factor: 6.939

7.  Surgical management of pure pancreatic fistulas.

Authors:  I Ihse; J Larsson; E Lindström
Journal:  Hepatogastroenterology       Date:  1994-06

8.  Gastrointestinal and pancreatic complications associated with severe pancreatitis.

Authors:  H S Ho; C F Frey
Journal:  Arch Surg       Date:  1995-08

9.  Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin.

Authors:  P Pederzoli; C Bassi; M Falconi; R Albrigo; I Vantini; R Micciolo
Journal:  Surg Gynecol Obstet       Date:  1986-11

10.  Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Authors:  J J Cullen; M G Sarr; D M Ilstrup
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

View more
  2 in total

1.  Effect of parenteral and enteral nutrition combined with octreotide on pancreatic exocrine secretion of patients with pancreatic fistula.

Authors:  Huan-Long Qin; Zhen-Dong Su; Yang Zou; You-Ben Fan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Outcome of surgery for chronic pancreatitis related pancreatic ascites and pancreatic pleural effusion.

Authors:  Arkadeep Dhali; Sukanta Ray; Tuhin Subhra Mandal; Somak Das; Avik Sarkar; Sujan Khamrui; Gopal Krishna Dhali
Journal:  Ann Med Surg (Lond)       Date:  2022-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.